{"id":"NCT02522780","sponsor":"Ferring Pharmaceuticals","briefTitle":"Mesalamine 2 g Sachet for the Maintenance of Clinical and Endoscopic Remission in Ulcerative Colitis (UC)","officialTitle":"A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Investigating the Efficacy and Safety of Mesalamine 2 g Extended Release Granules (Sachet) for Maintenance of Clinical and Endoscopic Remission in Ulcerative Colitis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-02-01","primaryCompletion":"2018-09-19","completion":"2018-09-19","firstPosted":"2015-08-13","resultsPosted":"2021-09-14","lastUpdate":"2021-11-08"},"enrollment":276,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Ulcerative Colitis"],"interventions":[{"type":"DRUG","name":"Mesalamine","otherNames":["Mesalazine","Pentasa"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Mesalamine","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this trial was to investigate the safety and efficacy of mesalamine 2 g extended release granules (sachet) once a day (QD) for maintenance of clinical and endoscopic remission in subjects with UC. The duration of treatment for each subject was 6 months.","primaryOutcome":{"measure":"Proportion of Subjects With Remission at Month 6","timeFrame":"Month 6","effectByArm":[{"arm":"Mesalamine","deltaMin":82,"sd":null},{"arm":"Placebo.","deltaMin":67,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":">0.05"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":11},"locations":{"siteCount":96,"countries":["United States","Bulgaria","Canada","Hungary","Latvia","Mexico","Poland","Russia","Serbia","Switzerland","Ukraine"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":137},"commonTop":["Colitis ulcerative","Glomerular filtration rate decreased","Alanine aminotransferase increased","Gamma-glutamyltransferase increased","Faecal calprotectin increased"]}}